184 related articles for article (PubMed ID: 8193992)
1. Altered neuropeptide Y effects on noradrenaline levels in the paraventricular nucleus of rats following aortic constriction.
Woo ND; Ganguly PK
Can J Cardiol; 1994 May; 10(4):471-6. PubMed ID: 8193992
[TBL] [Abstract][Full Text] [Related]
2. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats.
Bishop C; Parker GC; Coscina DV
Psychopharmacology (Berl); 2002 Jul; 162(3):265-72. PubMed ID: 12122484
[TBL] [Abstract][Full Text] [Related]
3. [A neuroendocrinological study on the mechanism of feeding-associated circadian rhythm of plasma corticosterone and feeding behaviour in rats: a role of neuropeptide Y in the paraventricular nucleus].
Yoshihara T
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):113-31. PubMed ID: 7744361
[TBL] [Abstract][Full Text] [Related]
4. The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.
Dube MG; Kalra SP; Kalra PS
Peptides; 2006 Sep; 27(9):2239-48. PubMed ID: 16759748
[TBL] [Abstract][Full Text] [Related]
5. Norepinephrine levels in paraventricular nucleus of spontaneously hypertensive rats: role of neuropeptide Y.
Woo ND; Mukherjee K; Ganguly PK
Am J Physiol; 1993 Sep; 265(3 Pt 2):H893-8. PubMed ID: 8214124
[TBL] [Abstract][Full Text] [Related]
6. Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass.
Romanova IV; Ramos EJ; Xu Y; Quinn R; Chen C; George ZM; Inui A; Das U; Meguid MM
J Am Coll Surg; 2004 Dec; 199(6):887-95. PubMed ID: 15555972
[TBL] [Abstract][Full Text] [Related]
7. Modulation of sympathetic activity by brain neuropeptide Y in cardiac hypertrophy.
Woo ND; Sahai A; Anderson WA; Ganguly PK
Am Heart J; 1991 Oct; 122(4 Pt 1):1028-34. PubMed ID: 1833961
[TBL] [Abstract][Full Text] [Related]
8. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y potentiation of potassium-induced noradrenaline release in the hypothalamic paraventricular nucleus of the rat in vivo.
Pavia JM; Hastings JA; Morris MJ
Brain Res; 1995 Aug; 690(1):108-11. PubMed ID: 7496795
[TBL] [Abstract][Full Text] [Related]
10. Change in the expression of NPY receptor subtypes Y1 and Y2 in central and peripheral neurons related to the control of blood pressure in rats following experimental hypertension.
Coelho EF; Ferrari MF; Maximino JR; Fior-Chadi DR
Neuropeptides; 2004; 38(2-3):77-82. PubMed ID: 15223269
[TBL] [Abstract][Full Text] [Related]
11. Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure.
Li YF; Cornish KG; Patel KP
Circ Res; 2003 Nov; 93(10):990-7. PubMed ID: 14576197
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors.
Tebbe JJ; Mronga S; Schäfer MK; Rüter J; Kobelt P; Mönnikes H
Am J Physiol Gastrointest Liver Physiol; 2003 Dec; 285(6):G1075-83. PubMed ID: 12855401
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y and [Leu31,Pro34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat.
Hastings JA; Pavia JM; Morris MJ
Brain Res; 1997 Mar; 750(1-2):301-4. PubMed ID: 9098556
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y loses its orexigenic effect in rats with lesions of the hypothalamic paraventricular nucleus.
Wang J; Yuan Z; Dong J; Zhang D; Usami T; Murata T; Narita K; Higuchi T
Endocr Res; 2013; 38(1):8-14. PubMed ID: 22594946
[TBL] [Abstract][Full Text] [Related]
15. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus.
Meguid MM; Ramos EJ; Laviano A; Varma M; Sato T; Chen C; Qi Y; Das UN
Peptides; 2004 Feb; 25(2):261-6. PubMed ID: 15063007
[TBL] [Abstract][Full Text] [Related]
16. Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers.
Fuxe K; Härfstrand A; Agnati LF; Kalia M; Fredholm B; Svensson T; Gustafsson JA; Lang R; Ganten D
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S1-13. PubMed ID: 2455156
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y suppresses thermogenic and cardiovascular sympathetic nerve activity via Y1 receptors in the paraventricular nucleus and dorsomedial hypothalamus.
Shi Z; Bonillas AC; Wong J; Padilla SL; Brooks VL
J Neuroendocrinol; 2021 Aug; 33(8):e13006. PubMed ID: 34235800
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y modulation of sympathetic activity in myocardial infarction.
Basu S; Sinha SK; Shao Q; Ganguly PK; Dhalla NS
J Am Coll Cardiol; 1996 Jun; 27(7):1796-803. PubMed ID: 8636570
[TBL] [Abstract][Full Text] [Related]
19. Effects of pinealectomy and exogenous melatonin on ghrelin and peptide YY in gastrointestinal system and neuropeptide Y in hypothalamic arcuate nucleus: immunohistochemical studies in male rats.
Aydin M; Canpolat S; Kuloğlu T; Yasar A; Colakoglu N; Kelestimur H
Regul Pept; 2008 Feb; 146(1-3):197-203. PubMed ID: 17936373
[TBL] [Abstract][Full Text] [Related]
20. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
